J&J may not meet US COVID-19 vaccine supply target by spring: NYT
Johnson & Johnson is facing unexpected delays in the manufacturing of its coronavirus vaccine and may not be able to supply the doses it promised the federal government by spring, the New York Times reported on Wednesday.
US federal officials have been told that J&J has fallen as much as two months behind the original production schedule and will not catch up until the end of April, when it was supposed to have delivered more than 60 million doses, the NYT reported, citing people familiar with the situation.
The company and the US Department of Health and Human Services did not immediately respond to Reuters requests for comment.
Earlier this week, J&J’s chief executive officer said the company was on track to have close to a billion COVID-19 vaccine doses by 2021-end.
(Source: Reuters)
Israeli-US estate tycoon brothers charged with decade-long sex trafficking
US, Canadian universities hire Israeli firms to curb pro-Palestinian protests, report says
US nuclear spending cause for concern
VIDEO | Yemenis praise the military for its successful operations against Israel
VIDEO | Israel continues to bomb Gaza homes
VIDEO | An insider's view of the country: Meybod City in Yazd
‘All wars have rules. All of those rules have been broken’ by Israel
VIDEO | Report flags India’s violation of rights of Rohingya detainees
Turkey's foreign minister meets Syria's de facto leader in Damascus
VIDEO | US Syria plots
'Next to impossible' to rescue patients from Gaza's Kamal Adwan Hospital: Director
PressTV NEWSLETTER
now
This makes it easy to access the Press TV website
